Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Double Blind, Placebo Controlled Study of Lu AA24493 in Patients With Friedreich's Ataxia to Evaluate Safety and Tolerability and to Explore Efficacy

NCT01016366 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT01016366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01016366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Double Blind, Placebo Controlled Study of Lu AA24493 in Patients With Friedreich's Ataxia to Evaluate Safety and Tolerability and to Explore Efficacy
Lead sponsor
H. Lundbeck A/S
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
April 30, 2011
Enrollment
36 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

friedreich's ataxia